Open AccessAcquisition of Sexually Transmitted Infections among Women Using a Variety of Contraceptive Options: A prospective Study among High‐risk African Women
Author(s) -
Kiweewa Flavia Matovu,
Brown Elizabeth,
Mishra Anu,
Nair Gonasagrie,
PalaneePhillips Thesla,
Mgodi Nyaradzo,
Nakabiito Clemensia,
Chakhtoura Nahida,
Hillier Sharon L,
Baeten Jared M
Publication year - 2019
Publication title -
journal of the international aids society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.724
H-Index - 62
ISSN - 1758-2652
DOI - 10.1002/jia2.25257
Subject(s) - medicine , gynecology , obstetrics , chlamydia trachomatis , hormonal contraception , gonorrhea , condom , incidence (geometry) , population , trichomonas vaginalis , medroxyprogesterone acetate , family planning , human immunodeficiency virus (hiv) , syphilis , environmental health , family medicine , estrogen , research methodology , physics , optics
In many African settings, women concurrently face substantial risk of human immunodeficiency virus type 1 ( HIV ‐1) infection, sexually transmitted infections ( STI s) and unintended pregnancies. Few studies have evaluated STI risk among users of hormonal implants and copper intrauterine devices ( IUD s) although these long‐acting reversible contraceptive methods are being promoted widely because of their benefits. Within a prospective study of women at risk for HIV ‐1, we compared the risk of acquisition of Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis among women using different contraceptive methods. Methods MTN ‐020/ ASPIRE was a randomized trial of the dapivirine vaginal ring for HIV ‐1 prevention among 2629 women aged 18 to 45 years from Malawi, South Africa, Uganda and Zimbabwe, of whom 2264 used copper IUD s or progestin‐based injectables or implants during follow‐up. Screening for the above STI s occurred semi‐annually. Results Over 3440 person‐years of follow‐up, 408 cases of C. trachomatis (incidence 11.86/100 person‐years), 196 of N. gonorrhoeae (5.70/100 person‐years) and 213 cases of T. vaginalis (6.19/100 person‐years) were detected. C. trachomatis and N. gonorrhoeae incidence were not significantly different across contraceptive methods. T. vaginalis incidence was significantly higher for copper IUD users compared to depot medroxyprogesterone acetate ( DMPA ), implant and norethisterone enanthate users. Conclusion Among African women at high HIV ‐1 risk, STI s were common. Risk of cervical infections did not differ across contraceptive methods. Significantly higher rates of T. vaginalis were observed among progestin‐based methods compared to copper IUD users. Overall, these findings call for more intensive routine screening for STI s, and they support current World Health Organization guidance that women should have a wide range of contraceptive options.